The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing

Transcription

1 The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified By: Medicine Management Committee 1. Introduction The Trust is committed to improving patients access to medicines and has ensured multi-disciplinary services have evolved to meet the needs of local service users, by using non-medical prescribing (NMP) to facilitate service redesign. The Trust s published aims, together with the strategic development of medicines management, form the basis for the development of NMP within the organisation with priority being afforded to: Enhancing the patient experience Optimising the skills and experience of non-medical healthcare professionals Improving efficiency and effectiveness Improving access to treatment Facilitating achievement of access targets Responding to changes in health care delivery and national objectives e.g. reducing outpatient prescribing. Ensuring safe clinical practice In order to achieve these objectives NMP can be developed in many areas and it has already been introduced in the following areas: Treatment of minor illnesses / ailments / injuries within Emergency Departments, walk-in and treatment centres Management of specialist / chronic conditions e.g. pain management, palliative care, allergy / immunology Management of minor conditions by nurses, midwives and health visitors working within community locations. Management of patients admitted for cardiothoracic surgery Roles where nurse practitioners have replaced junior doctors Management of acutely ill patients on critical care, within a recognised framework. When developing or refining any service, directorate management teams should consider opportunities for NMP and where appropriate integrate them into workforce planning processes. When considering the potential for NMP the following issues should be considered: Structure of the existing multi-professional team Page 1 of 12

2 The potential benefits and challenges from the perspective of the patient, professional team and directorate (quality, economic, resources, prescribing budget, training, support and supervision of the individual, team and service). Knowledge and skills and education of the professional Patient safety and best practice 2. Scope The aim of NMP is to give patients more streamlined access to medicines, improve access to services and make better use of nurses, pharmacists and other health professionals skills. The Department of Health has issued clear guidance about the individual staff groups permitted to prescribe and the legal boundaries within which they must practice (Appendix 1). The successful development of NMP within the Trust has been driven by the vision, aspiration and enthusiasm of senior practitioners and managers who identified the potential benefits that NMP has for patients and many of these benefits have already been realised. The number of non-medical prescribers within the Trust continues to grow month by month with a full list currently available from the Trust NMP Lead. Legislation was passed in August 2013 allowing the introduction of independent prescribing responsibilities for a wider group of healthcare professionals including physiotherapists and podiatrists and already individuals within these professional groups are working as NMPs within the Trust. Further developments are planned with supplementary prescribing for dietitians and radiographers under development and courses expected to start in It is essential that these developments are supported by a robust and consistent governance framework. This will be steered by the NMP Group, established in November Aims This document aims to: Identify a clear framework for the ongoing development of non-medical prescribing (NMP) within the Trust, in line with national recommendations and good practice. Define the process for the implementation of NMP within Directorates and for individual practitioners throughout the Trust. Define the clinical governance framework required to support NMP and ensure measures such as audit and evaluation are carried out effectively. 4. Duties and responsibilities 4.1 Organisation The implementation of NMP is supported by the Trust s Clinical Governance and Medicines Management systems. 4.2 The NMP Group The Non-Medical Prescribing Group (NMP Group), supported by the Trust s Medicines Management Committee (MMC), maintains overall responsibility for the Page 2 of 12

3 strategic development, integration, implementation and monitoring of NMP within the organisation. The remit of the NMP Group is to: Review, maintain and update the NMP Strategy for the Trust Ensure all NMP developments within the Trust are evidence-based and in line with national direction and policy Discuss and approve all appropriate applications by NMPs to prescribe within the Trust. Ensure all NMPs adhere to professional guidance from the relevant regulatory body Review and approve Patient Group Directions then refer on to the Chair of the MMC for ratification Promote best practice and share experience in the application of NMP within the Trust Act as a professional forum for discussion of NMP issues within the Trust Consider new opportunities and professional development for both new and existing NMPs Consider new areas of opportunity where NMP could be developed Form links with the local universities providing NMP courses and be part of any course review process Ensure arrangements are in place to audit and evaluate practice, measure competence and monitor performance of NMPs. 4.3 Line Manager The practitioner s line manager is responsible for: Identifying areas and individuals that would benefit from NMP and supporting individuals from the application process through to completion of the course and in their new role Ensuring that NMPs have a personal development plan and have access to appropriate continuing professional development opportunities to enable them to maintain their prescribing competencies. Assessing knowledge and clinical / prescribing competences and checking prescribers activity is audited at least on an annual basis. Ensure NMP is included in the practitioner s job description 5. Application and registration process 5.1 Application by practitioners to study In advance of an application to university practitioners are required to: Acquire verbal support from their Directorate manager or matron and identify a designated medical practitioner who will act as their mentor Apply for study leave and ensure they will be released and available for all study days Page 3 of 12

4 Ensure NMP has been identified within their professional duties and is clearly stated within their job description Have completed a CRB check within the last 3 years (NMC requirement) Identify a NMP buddy who has been practising as a NMP for at least one year. This individual will promote safe prescribing and ensure studying and new prescribers meet their full potential Provide evidence of their ability to learn at degree level Provide evidence of their clinical skills, preferably as accredited training Provide evidence of basic mathematics and calculation skills Contact the chair of the NMP Group to discuss their application Submit a signed written application to the chair of the NMP Group to be presented at the next appropriate meeting If successful the individual will be informed in writing by the chair of the NMP Group. They can then apply to the university for a place on the next available course. Accredited training of NMPs will be undertaken at a higher education institute. Details pertaining to local training programmes can be found on the following websites or for nurses and AHPs and for pharmacists. Note: The practitioner must obtain a letter of Trust support from the chair of the NMP Group before applying to the university. 5.2 Post Qualification or non-medical prescribers joining the Trust Practitioners who have successfully completed an accredited NMP training programme and existing NMP who join the Trust must complete the following to enable them to prescribe within the Trust: Register their qualification with their professional body and maintain their professional registration Confirm arrangements for ongoing support and supervision from their medical mentor and NMP buddy Agree the parameters of their prescribing with their directorate and the Chair of the NMP Group then submit the final completed proposal to the Chair of the NMP Group for discussion at the next meeting. NMPs will be given authority to prescribe and informed by letter. NMPs must not begin prescribing until they receive written authorisation. Prescribers may often be required to use their individual NMC number to confirm their identity, particularly in community settings. Outpatient prescription pads can be obtained from the Pharmacy Department at RVI and Freeman Hospital for hospital NMPs. Prescription pads will be ordered for community practitioners on an individual basis by the pharmacy administrator for NMP. A request must be made and the appropriate paperwork completed once Trust approval for NMP has been granted. These pads can be collected from the Pharmacy Department at the Freeman Hospital. Page 4 of 12

5 5.3 The Trust NMP Register The Trust NMP Register, which is maintained by the administrator for NMP and accessible via the Trust NMP Lead, contains the following information: The name of the non-medical prescriber, clinical role, specialist area of Practice (for hospital based practitioners only) Scanned signature Prescribing status (Independent and / or Supplementary or Community Practitioner Nurse Prescriber) Categories of drugs that may be prescribed by the practitioner (if appropriate) 5.4 Guidance and procedures Approved NMPs must: Ensure that patients are (wherever possible) made aware that they are being managed by a NMP, including the implications for practice and intervention. In certain situations this may not be possible e.g. unconscious or confused patients, emergency situations. Prescribe from the local formulary within their level of competence / clinical experience and in accordance with local, national and professional guidelines Maintain accurate, legible, unambiguous records that ensure patient safety and allow optimal communication between the patient and their healthcare team. Report any medication incidents or near misses in accordance with Trust procedures Report any suspected adverse drug reactions to the clinician responsible for the patient s ongoing care and complete a yellow card where appropriate. Maintain documented evidence of their evolving clinical knowledge and prescribing competencies (as a portfolio of evidence) Review and evaluate their practice on an annual basis and present results to the Trust NMP Group, using methods such as audit and prescribing assessment Discuss any expansions in the classifications of drugs that they wish to prescribe or any significant modifications to practice with the NMP Lead Pharmacist Immediately inform the organisation of any change in their personal details / role within the organisation or any circumstances that might adversely influence their ability to practice Undertake a negotiated period of supervised practice following a break in NMP practice. The significance of the break in practice will be determined by the NMP in consultation with their medical mentor and line manager. The period of supervised practice will be determined by the NMP in consultation with their medical mentor. Inform HR and the chair of the NMP Group that they are a NMP if they leave the Trust Page 5 of 12

6 Approved NMPs must never: Prescribe outside of their area of competence or clinical experience Administer or dispense any medicine they have prescribed Prescribe any medication for themselves or, barring exceptional circumstances, for anyone with whom they have a close personal or emotional relationship Promote commercial products or services and must declare any financial or other interests in organisations providing any such goods or services Leave prescription pads unattended. When not in use prescription pads must be stored in a designated locked area. The Assistant Director of Pharmacy Clinical Services must be notified if a prescription pad is lost or stolen Governance Non-medical prescribers must always prescribe within their area of expertise and competence and feel comfortable with the prescribing decisions they have made. It is essential that they have medical support either from a named mentor or from within the team they work with. A NMP should never be pressured to prescribe something they are not familiar with and a referral system should be in place for when such a situation arises. The NMP Group will ensure prescribing practices are regularly audited and data reviewed to ensure practitioners are prescribing appropriately. 5.6 Liability The Trust has a duty of care to patients and is vicariously liable for the actions or omissions of its employees. The Trust will support non-medical prescribers who: Complete an accredited period of study pertaining to NMP and have acquired authorisation from the organisation Prescribe within their level of clinical experience and competence and in accordance with local, national and professional guidelines Maintain their underlying knowledge and clinical / prescribing competences together with their professional registration. The Trust has financial responsibility for the negligent acts of its staff in the course of their bona fide activities. This responsibility is protected under indemnity schemes which cover clinical and non-clinical liabilities for harm caused to patients, visitors and employees and also extends to individual staff employed by the Trust. 6. Training Accredited prescribing courses are available from Northumbria, Teesside and Sunderland Universities. See Appendix 3 for further details Page 6 of 12

7 7. Equality and Diversity The Trust is committed to ensuring that, as far as is reasonably practicable, the way we provide services to the public and the way we treat our staff reflects their individual needs and does not discriminate against individuals or groups on any grounds. 8. Monitoring Compliance Standard / process / issue Maintain an up to date register of all Trust NMPs. Ensure all NMPs prescribe within their area of competence. Monitoring and audit Method By Committee Frequency 10% of all records reviewed to ensure nurses remain employed by Nuth Prescribing data reviewed for 10% of registered NMPs Chair of NMP group MMC Chair of NMP group MMC Annual Annual 9. Consultation and Review This strategy was developed in consultation with senior nursing, pharmacy and medical staff within the Trust. Compliance with the strategy will be monitored by the NMP Group who will acquire feedback from those parties identified within the strategy together with local educational providers. An annual review of progress against the strategy will be undertaken by the NMP Group and presented to the Trust s Medicines Management Committee. 10. Implementation This document will be available on the Trust intranet for all staff to view. Individuals who express an interest in developing as NMPs will be signposted accordingly. 11. References / Bibliography DoH (2006) Improving patients access to medicines A Guide to Implementing Nurse and Pharmacist Independent prescribing within the NHS in England (2006) endition=web Page 7 of 12

8 DoH (2006) Medicines Matters dguidance/dh_ DoH (2008) The Non-Medical Prescribing Programme henon-medicalprescribingprogramme/index.htm The National Prescribing Centre (Non Medical Prescribing) Page 8 of 12

9 Appendix 1 Categories of Non Medical Prescribers Nurse Independent Prescribers (V300) (previously known as extended formulary nurse prescribers) are able to prescribe any licensed or unlicensed medicine for any medical condition within their competence. This also applies to all schedule 2 to 5 controlled drugs with the exception of prescribing of cocaine, diamorphine or dipipanone for the treatment of addiction (restricted to Home Office licensed doctors).. Pharmacist Independent Prescribers are able to prescribe any licensed medicine for any medical condition within their competence including schedule 2-5 controlled drugs, with the exception of prescribing of cocaine, diamorphine and dipapinone for the treatment of addiction (restricted to Home Office licensed doctors) Optometrist Independent Prescribers can prescribe any licensed medicine for ocular conditions, affecting the eye and the tissues surrounding the eye, within their recognised area of expertise and competence, excluding controlled drugs. Physiotherapist, radiographer and dietitian independent prescribers are able to prescribe a range of drugs that are appropriate to their area and scope of practice. Supplementary nurse, pharmacist, physiotherapist, radiographer, optometrist or chiropodist / podiatrist prescribers are able to prescribe any medicine, including unlicensed medicines, providing they are defined within a patient s clinical management plan (CMP).CMPs must be developed / agreed in partnership with a medical independent prescriber, i.e. a doctor (including a GP or ophthalmologist) or a dentist. Community Practitioner Nurse Prescribers (V150) can only prescribe dressings, appliances and licensed medicines listed in the Nurse Prescribers' Formulary for Community Practitioners. Page 9 of 12

10 Appendix 2 Prerequisites for Practitioners applying to undertake an accredited NMP training programme All applicants must Have a valid registration with their professional body Be appointed to a substantive post where they will have the need and opportunity to act as an independent / supplementary prescriber upon qualification. Demonstrate the ability to study at degree level (Quality Assurance Agency (QAA) for Higher Education level 3). Demonstrate Clinical Skills experience (preferably as a formal qualification) Have completed a CRB check within the last 3 years (NMC requirement) Be able to provide evidence of numeracy skills e.g. GCSE Maths, feedback from on-line tutorials e.g. Authentic World or Kings College London ( Identify a Designated Medical Prescriber (DMP) who will be willing / able to contribute to and supervise the learning in practice element of their training and provide post qualification clinical supervision. Additional requirements First level Registered Nurses / Midwives: Have at least three years post-registration experience of which at least one year immediately preceding their application must be in the clinical area in which they intend to prescribe. Provide evidence of competence in history taking, undertaking a clinical assessment and making a diagnosis i.e. comprehensively assess a patient s physiological and/or psychological condition, understand the underlying pathology and identify the appropriate medicines regime. Registered Pharmacists: Have at least three years experience practicing as a registered pharmacist in a clinical environment (hospital or community), and at least one year immediately preceding their application must be in the clinical area in which they intend to prescribe. Be able to demonstrate competence to prescribe in the area in which they will prescribe following training. Registered Optometrist: Have at least two years post registration experience. Be able to demonstrate competence to prescribe in the area in which they will prescribe following training. Registered Physiotherapists, Chiropodists / Podiatrists, Dietitians and Radiographers Be a senior practitioner with at least three years post-registration experience of which at least one year immediately preceding their application must be in the Page 10 of 12

11 clinical area in which they intend to prescribe. It is highly likely that individuals will be practitioners in senior clinical / specialist posts. Be able to demonstrate competence to prescribe in the clinical area in which they will prescribe following training. Page 11 of 12

12 Appendix 3 Northumbria University delivers a Community Practitioner Nurse Prescriber course (V150) for community staff nurses who wish to prescribe from the Community Nurse Formulary. Northumbria University also offers a part-time Independent Nurse Prescribing course (V300) for nurses. This course consists of one day theory per week (Thursday) for 26 weeks and requires 12 days supervised practice. The university intends to offer the programme twice per academic year (starting September and March). It also offers prescribing courses for AHPs, some of which are currently under development. Teesside University also offers a prescribing course for nurses and AHPs further details are available from their website. The University of Sunderland offers a part-time prescribing course for pharmacists. This involves 8 taught theory days (Tuesdays) and 90 hours of supervised practice. The University plan to run the course twice a year (in October and March) Page 12 of 12

13 The Newcastle upon Tyne Hospitals NHS Foundation Trust Equality Analysis Form A This form must be completed and attached to any procedural document when submitted to the appropriate committee for consideration and approval. PART 1 1. Assessment Date: 12/10/16 2. Name of policy / strategy / service: Non-Medical Prescribing Strategy 3. Name and designation of Author: Lorna Clark, Assistant Director of Pharmacy 4. Names & designations of those involved in the impact analysis screening process: 5. Is this a: Policy Strategy X Service Is this: New Revised X Who is affected Employees X Service Users Wider Community 6. What are the main aims, objectives of the policy, strategy, or service and the intended outcomes? (These can be cut and pasted from your policy) This document aims to: Identify a clear framework for the ongoing development of non-medical prescribing (NMP) within the Trust, in line with national recommendations and good practice. Define the process for the implementation of NMP within Directorates and for individual practitioners throughout the Trust. Define the clinical governance framework required to support NMP and ensure measures such as audit and evaluation are carried out effectively. 7. Does this policy, strategy, or service have any equality implications? Yes No x

14 If No, state reasons and the information used to make this decision, please refer to paragraph 2.3 of the Equality Analysis Guidance before providing reasons: As per previous strategy. Refers to all non-medical staff who are legally entitled to act as prescribers. No exclusions related to any of the categories below.

15 8. Summary of evidence related to protected characteristics Protected Characteristic Race / Ethnic origin (including gypsies and travellers) Sex (male/ female) Religion and Belief Sexual orientation including lesbian, gay and bisexual people Age Disability learning difficulties, physical disability, sensory impairment and mental health. Consider the needs of carers in this section Gender Re-assignment Marriage and Civil Partnership Maternity / Pregnancy Evidence, i.e. What evidence do you have that the Trust is meeting the needs of people in various protected Groups Does evidence/engagement highlight areas of direct or indirect discrimination? If yes describe steps to be taken to address (by whom, completion date and review date) Does the evidence highlight any areas to advance opportunities or foster good relations. If yes what steps will be taken? (by whom, completion date and review date) 9. Are there any gaps in the evidence outlined above? If yes how will these be rectified? 10. Engagement has taken place with people who have protected characteristics and will continue through the Equality Delivery System and the Equality Diversity and Human Rights Group. Please note you may require further engagement in respect of any significant changes to policies, new developments and or changes to service delivery. In such circumstances please contact the Equality and Diversity Lead or the Involvement and Equalities Officer. Do you require further engagement? Yes No x 11. Could the policy, strategy or service have a negative impact on human rights? (E.g. the right to respect for private and family life, the right to a fair hearing and the right to education? No

16 PART 2 Name: Lorna Clark Date of completion: 12/10/16 (If any reader of this procedural document identifies a potential discriminatory impact that has not been identified, please refer to the Policy Author identified above, together with any suggestions for action required to avoid/reduce the impact.)